Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...